New test for bile duct cancer during ERCP
Part of Cancer clinical trials.
This study looks at a new way to detect bile duct cancer (cholangiocarcinoma) using samples taken during a routine ERCP. It tests a special protein marker that might help doctors diagnose the condition more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a narrowing or mass in your bile ducts seen on an imaging test.
- You are already scheduled for an ERCP procedure, which is a test to look at your bile ducts.
- You are 18 years old or older.
- You are able to give your own consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a bile sample to help diagnose the cause of a bile duct stricture (a narrowing) that was not clearly identified by standard tests. It may help patients avoid more invasive procedures.
This study is testing a new blood test to help find cholangiocarcinoma (bile duct cancer) earlier and more easily. If you are scheduled for surgery for this cancer, this test may help confirm the diagnosis without more invasive procedures.
This study is testing a new lab technique to see if it can accurately diagnose a type of bile duct cancer called cholangiocarcinoma from stored tissue samples. It might help doctors diagnose this cancer more accurately in the future.
This trial tests whether a sample of bile (a fluid produced by your liver) can help doctors diagnose bile duct cancer more accurately. If you have a narrowing in your bile duct and need a procedure to take a tissue sample, you may be able to participate.
This study tests a new digital scope and ultrasound to look at narrowed bile ducts that don't cause jaundice. It may help doctors see the narrowing more clearly and guide treatment.
This study looks for new ways to measure cancer-related “biomarkers” (signals in blood or tumor samples) in people with bile duct cancer or gallbladder cancer. The goal is to improve how these cancers are identified and tracked, which could help doctors make better treatment decisions.
Hear when a new Cholangiocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.